Earnings

Sector Snap: Life Science Tools Upgraded

 

NEW YORK (AP) — A Barclays analyst raised his rating on the life science instrument sector Monday, saying 2010 should be a strong year due to greater demand from customers and federal stimulus funding.

C. Anthony Butler upgraded the life science enabling tools sector to "Positive" from "Neutral," and raised his rating on Agilent Technologies Inc. and Waters Corp. to "Overweight" form "Equal Weight." He believes demand from customers in the industrial market is going to improve, and said other customers will have more to spend as stimulus funds are disbursed.

"Life science tools names have disproportionate exposure to attractive academic and government research end-markets, which are poised to benefit from significant stimulus inflows over the coming years," Butler said. He named Waters and Life Technologies Corp. as his top picks in the sector.

The analyst said Waters of Milford, Mass., has the highest profit margin of any company in the sector, while Agilent, Santa Clara, Calif., will get a significant profit boost from its purchase of Varian Inc. He raised his price target on Waters shares to $65 from $55, and his target for Agilent stock to $33 per share from $25.

In afternoon trading, Agilent shares added 43 cents to $28.80, and Waters stock rose $1.06 to $56.38. Shares of Life Technologies set an annual high of $48.85, but later declined 29 cents to $48.17.

>To order reprints of this article, click here: Reprints

Copyright 2009 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

TheStreet Premium Services

Jim Cramer
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn More
OptionsProfits
OptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn More
Real Money
Real Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn More
Stocks Under $10
Stocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn More
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
blog comments powered by Disqus
Dow Jones S&P 500 NASDAQ 10-Year Note
12,393.45 1,310.33 2,827.34 15.81
Oil *
101.78
DOWN
26.41
DOWN
2.99
DOWN
10.02
DOWN
0.44
10 Yr
1.58%
SPDR Gold
151.62
-0.21%
-0.23%
-0.35%
-2.71%
Data delayed 20 minutes

Top Stories and Tools

Articles From

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy.
Podcasts

Connect with TheStreet